search reports
Categories
Categories
Filter By
Published
GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams.
Title Published Price
Swine and Avian Influenza Drug Development Pipeline Review, 2017
Code: gbi0028 | Published Date : 20 November, 2017 | No of Pages : 119
... read more
20 November, 2017 $ 3995
Sickle Cell Disease Drug Development Pipeline Review, 2017
Code: gbi0027 | Published Date : 17 November, 2017 | No of Pages : 77
... read more
17 November, 2017 $ 3995
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017
Code: gbi0026 | Published Date : 16 November, 2017 | No of Pages : 244
... read more
16 November, 2017 $ 3995
Cancer Supportive Care Drug Development Pipeline Review, 2017
Code: gbi0025 | Published Date : 14 November, 2017 | No of Pages : 128
... read more
14 November, 2017 $ 3995
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
Code: gbi0023 | Published Date : 01 November, 2017 | No of Pages : 133
... read more
01 November, 2017 $ 4995
Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD
Code: gbi0024 | Published Date : 01 November, 2017 | No of Pages : 149
... read more
01 November, 2017 $ 6995
Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease
Code: gbi0022 | Published Date : 03 October, 2017 | No of Pages : 72
... read more
03 October, 2017 $ 6995
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Code: gbi0019 | Published Date : 01 October, 2017 | No of Pages : 202
... read more
01 October, 2017 $ 4995
Frontier Pharma: Ophthalmology Therapeutics - Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune Signaling Drugs
Code: gbi0021 | Published Date : 01 October, 2017 | No of Pages : 71
... read more
01 October, 2017 $ 6995
Pneumonia Drug Development Pipeline Review, 2017
Code: gbi0017 | Published Date : 26 September, 2017 | No of Pages : 123
... read more
26 September, 2017 $ 3995
1 2 3 4 5 6 7 8 9 10 ...